We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.2B
AUM Growth
-$229M
Cap. Flow
-$321M
Cap. Flow %
-26.76%
Top 10 Hldgs %
3.64%
Holding
2,198
New
503
Increased
500
Reduced
583
Closed
602

Top Buys

Rank Stock Value
1
SFM icon
Sprouts Farmers Market
SFM
+$6M
2
EOG icon
EOG Resources
EOG
+$4.13M
3
ACN icon
Accenture
ACN
+$4.06M
4
QRVO icon
Qorvo
QRVO
+$3.89M
5
INFA
Informatica
INFA
+$3.49M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$14.5M
2
AAPL icon
Apple
AAPL
+$13.1M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.08M
5
JPM icon
JPMorgan Chase
JPM
+$6.68M

Sector Composition

Rank Sector Weight
1 Technology 16.89%
2 Healthcare 15.77%
3 Consumer Discretionary 12.73%
4 Financials 12.52%
5 Industrials 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTIL icon
1526
Precision BioSciences
DTIL
$207M
$98K 0.01%
+17,722
New +$84.9K
DXLG icon
1527
Destination XL Group
DXLG
$35.4M
$97K 0.01%
+74,368
New +$97.5K
NL icon
1528
NLI Holdings
NL
$317M
$96K 0.01%
15,661
BWEN icon
1529
Broadwind
BWEN
$109M
$95K 0.01%
45,207
-1,777
-4% -$3.97K
CURV icon
1530
Torrid Holdings
CURV
$260M
$93K 0.01%
+52,946
New +$122K
CIG icon
1531
CEMIG Preferred Shares
CIG
$6.01B
$92K 0.01%
43,422
+12,145
+39% +$23.8K
KPTI icon
1532
Karyopharm Therapeutics
KPTI
$48M
$92K 0.01%
14,076
+182
+1% +$979
CRVO icon
1533
CervoMed
CRVO
$26.6M
$91K 0.01%
+11,307
New +$97K
INTZ
1534
Intrusion
INTZ
$17.3M
$91K 0.01%
+56,954
New +$108K
CSTE icon
1535
Caesarstone
CSTE
$79.5M
$89K 0.01%
+55,798
New +$90.9K
GSIT icon
1536
GSI Technology
GSIT
$258M
$88K 0.01%
+23,908
New +$90.1K
PGRE
1537
DELISTED
Paramount Group
PGRE
$87K 0.01%
+13,287
New +$88.3K
WDH
1538
Waterdrop
WDH
$359M
$87K 0.01%
46,065
+21,953
+91% +$38.4K
MYPS icon
1539
PLAYSTUDIOS Inc
MYPS
$90.1M
$84K 0.01%
86,999
+59,028
+211% +$63.6K
VIR icon
1540
Vir Biotechnology
VIR
$1.49B
$84K 0.01%
14,746
-53,062
-78% -$271K
RSSS icon
1541
Research Solutions
RSSS
$72.2M
$82K 0.01%
22,068
-8,573
-28% -$26.3K
REPL icon
1542
Replimune Group
REPL
$1.01B
$81K 0.01%
+19,286
New +$123K
SCYX icon
1543
SCYNEXIS
SCYX
$52M
$80K 0.01%
13,053
+6,365
+95% +$43.1K
VLN icon
1544
Valens Semiconductor
VLN
$188M
$80K 0.01%
44,499
+225
+0.5% +$508
FUBO icon
1545
FuboTV Inc
FUBO
$273M
$79K 0.01%
1,588
-13,983
-90% -$634K
III icon
1546
Information Services Group
III
$251M
$77K 0.01%
+13,355
New +$66.4K
VATE icon
1547
INNOVATE Corp
VATE
$165M
$77K 0.01%
15,821
-6,751
-30% -$35.1K
KRMD icon
1548
KORU Medical Systems
KRMD
$164M
$75K 0.01%
19,706
-39,814
-67% -$152K
SLQT icon
1549
SelectQuote
SLQT
$121M
$75K 0.01%
38,144
+17,198
+82% +$36.4K
CVU icon
1550
CPI Aerostructures
CVU
$68.5M
$71K 0.01%
28,006
+1,918
+7% +$5.67K

Similar funds

GSA Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, GSA Capital Partners held 2,198 positions worth $1.2B, down 16% from $1.43B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners withdrew a net $321M in Q3 2025, closing 602 positions and reducing 583 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $8.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in EOG Resources worth $3.88M.

  • GSA Capital Partners's largest Q3 2025 buy was EOG Resources: 34,604 shares worth $3.88M.
  • GSA Capital Partners added most to Sprouts Farmers Market in Q3 2025, an estimated $6M increase.
  • GSA Capital Partners's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $14.5M.
  • GSA Capital Partners fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $8.08M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.2B portfolio in Q3 2025.
  • GSA Capital Partners opened 503 new positions and closed 602 in Q3 2025.
  • GSA Capital Partners's portfolio value fell 16% quarter-over-quarter to $1.2B.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.